Hub: https://www.merlintrader.com/lb-pharmaceuticals-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
Hub: https://www.merlintrader.com/lb-pharmaceuticals-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
https://fundspec.ai/s/LBRX/earnings
Momentum scores on thousands of tickers, refreshed every night.
https://fundspec.ai/s/LBRX/earnings
Momentum scores on thousands of tickers, refreshed every night.
On November 5, 2026, LB Pharmaceuticals Inc issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished hereto as Exhibit 99.1. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is bein...
On November 5, 2026, LB Pharmaceuticals Inc issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished hereto as Exhibit 99.1. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is bein...
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-reports-third-quarter-2026-financial-results-and-a1o5afc9j0j2.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-reports-third-quarter-2026-financial-results-and-a1o5afc9j0j2.html?utm_source=stocktitan-bluesky&utm_medium=social
LBRX Stock Hub: LB Pharmaceuticals News, LB-102 and Schizophrenia
www.merlintrader.com/lb-pharmaceu...
LBRX Stock Hub: LB Pharmaceuticals News, LB-102 and Schizophrenia
www.merlintrader.com/lb-pharmaceu...
Miller Joseph M (Chief Financial Officer) reported special transactions (Non-P/S).
Miller Joseph M (Chief Financial Officer) reported special transactions (Non-P/S).
Kozauer Susan Gani (Chief Medical Officer) reported special transactions (Non-P/S).
Kozauer Susan Gani (Chief Medical Officer) reported special transactions (Non-P/S).
Jpmorgan Chase: 5.2% → 4.3% (about $50M)
1,497,293 → 1,401,790 shares
SEC Schedule 13G/A · filed Oct 13
#Investing #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Jpmorgan Chase: 5.2% → 4.3% (about $50M)
1,497,293 → 1,401,790 shares
SEC Schedule 13G/A · filed Oct 13
#Investing #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Explore the clinical evidence, development plans and financial risks in our research hub.
https://www.merlintrader.com/lb-pharmaceuticals-stock-hub/
Explore the clinical evidence, development plans and financial risks in our research hub.
https://www.merlintrader.com/lb-pharmaceuticals-stock-hub/
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-reports-inducement-grants-to-new-employee-under-0f1khslr5bzq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-reports-inducement-grants-to-new-employee-under-0f1khslr5bzq.html?utm_source=stocktitan-bluesky&utm_medium=social
Kozauer Susan Gani (Chief Medical Officer) filed Form 3 reporting no initial stock ownership.
Kozauer Susan Gani (Chief Medical Officer) filed Form 3 reporting no initial stock ownership.
On September 15, 2026, the Company issued a press release announcing the appointment of Dr. Kozauer as the Company’s Chief Medical Officer.
On September 15, 2026, the Company issued a press release announcing the appointment of Dr. Kozauer as the Company’s Chief Medical Officer.
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-appoints-susan-g-kozauer-m-d-as-chief-medical-vgsqamyxa8hu.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-appoints-susan-g-kozauer-m-d-as-chief-medical-vgsqamyxa8hu.html?utm_source=stocktitan-bluesky&utm_medium=social
On September 3, 2026, the Company issued a press release announcing the appointment of Mr. Miller as the Company’s Chief Financial Officer.
On September 3, 2026, the Company issued a press release announcing the appointment of Mr. Miller as the Company’s Chief Financial Officer.
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-appoints-joseph-miller-as-chief-financial-uyfxkf2x6anz.html
https://www.stocktitan.net/news/LBRX/lb-pharmaceuticals-appoints-joseph-miller-as-chief-financial-uyfxkf2x6anz.html
$LBRX 10-K → https://filingdiff.com/ticker/LBRX/0001193125-26-126368/
$LBRX 10-K → https://filingdiff.com/ticker/LBRX/0001193125-26-126368/
$LBRX 10-Q → https://filingdiff.com/ticker/LBRX/0001193125-26-219607/
$LBRX 10-Q → https://filingdiff.com/ticker/LBRX/0001193125-26-219607/